Rotenstein, L
Nathan, A
Ghobrial, I
Antin, J
Parnes, A
Article History
First Online: 6 June 2016
Competing interests
: AP has received compensation as a consultant for Alexion, the manufacturer of eculizumab. The remaining authors declare no conflict of interest.
Free to read: This content has been made available to all.